Treatment of Gilles de la Tourette's syndrome

Eight-year, practice-based experience in a predominantly adult population

M. M. Mesulam, Ronald Carl Petersen

Research output: Contribution to journalArticle

24 Citations (Scopus)

Abstract

Over 86% of 58 patients with Gilles de la Tourette's syndrome achieved effective pharmacologic control of the symptoms for 3 months or longer. Differences in response patterns were common among patients and required individualized tailoring of management. Dopamine-blocking neuroleptics were the mainstay of therapy. However, frequent mid-course alterations were required as previously successful drugs stopped working or as their side effects became intolerable. While haloperidol and now pimozide are most frequently used, trifluoperazine and thiothixene can provide superior refief in individual patients. A combination of neuroleptics or even a rotation from one to another may occasionally become necessary. No tardive dyskinesia was encountered in this population. Clonidine proved inferior to neuroleptics in the treatment of the motor and vocal tics, but may have a role in some patients with prominent obsessive-compulsive symptomatology.

Original languageEnglish (US)
Pages (from-to)1828-1833
Number of pages6
JournalNeurology
Volume37
Issue number12
StatePublished - 1987
Externally publishedYes

Fingerprint

Tourette Syndrome
Antipsychotic Agents
Tics
Population
Thiothixene
Pimozide
Trifluoperazine
Clonidine
Haloperidol
Therapeutics
Dopamine
Pharmaceutical Preparations

ASJC Scopus subject areas

  • Neuroscience(all)

Cite this

Treatment of Gilles de la Tourette's syndrome : Eight-year, practice-based experience in a predominantly adult population. / Mesulam, M. M.; Petersen, Ronald Carl.

In: Neurology, Vol. 37, No. 12, 1987, p. 1828-1833.

Research output: Contribution to journalArticle

@article{07401c886b0c44109ad8eeb242df92a6,
title = "Treatment of Gilles de la Tourette's syndrome: Eight-year, practice-based experience in a predominantly adult population",
abstract = "Over 86{\%} of 58 patients with Gilles de la Tourette's syndrome achieved effective pharmacologic control of the symptoms for 3 months or longer. Differences in response patterns were common among patients and required individualized tailoring of management. Dopamine-blocking neuroleptics were the mainstay of therapy. However, frequent mid-course alterations were required as previously successful drugs stopped working or as their side effects became intolerable. While haloperidol and now pimozide are most frequently used, trifluoperazine and thiothixene can provide superior refief in individual patients. A combination of neuroleptics or even a rotation from one to another may occasionally become necessary. No tardive dyskinesia was encountered in this population. Clonidine proved inferior to neuroleptics in the treatment of the motor and vocal tics, but may have a role in some patients with prominent obsessive-compulsive symptomatology.",
author = "Mesulam, {M. M.} and Petersen, {Ronald Carl}",
year = "1987",
language = "English (US)",
volume = "37",
pages = "1828--1833",
journal = "Neurology",
issn = "0028-3878",
publisher = "Lippincott Williams and Wilkins",
number = "12",

}

TY - JOUR

T1 - Treatment of Gilles de la Tourette's syndrome

T2 - Eight-year, practice-based experience in a predominantly adult population

AU - Mesulam, M. M.

AU - Petersen, Ronald Carl

PY - 1987

Y1 - 1987

N2 - Over 86% of 58 patients with Gilles de la Tourette's syndrome achieved effective pharmacologic control of the symptoms for 3 months or longer. Differences in response patterns were common among patients and required individualized tailoring of management. Dopamine-blocking neuroleptics were the mainstay of therapy. However, frequent mid-course alterations were required as previously successful drugs stopped working or as their side effects became intolerable. While haloperidol and now pimozide are most frequently used, trifluoperazine and thiothixene can provide superior refief in individual patients. A combination of neuroleptics or even a rotation from one to another may occasionally become necessary. No tardive dyskinesia was encountered in this population. Clonidine proved inferior to neuroleptics in the treatment of the motor and vocal tics, but may have a role in some patients with prominent obsessive-compulsive symptomatology.

AB - Over 86% of 58 patients with Gilles de la Tourette's syndrome achieved effective pharmacologic control of the symptoms for 3 months or longer. Differences in response patterns were common among patients and required individualized tailoring of management. Dopamine-blocking neuroleptics were the mainstay of therapy. However, frequent mid-course alterations were required as previously successful drugs stopped working or as their side effects became intolerable. While haloperidol and now pimozide are most frequently used, trifluoperazine and thiothixene can provide superior refief in individual patients. A combination of neuroleptics or even a rotation from one to another may occasionally become necessary. No tardive dyskinesia was encountered in this population. Clonidine proved inferior to neuroleptics in the treatment of the motor and vocal tics, but may have a role in some patients with prominent obsessive-compulsive symptomatology.

UR - http://www.scopus.com/inward/record.url?scp=0023607665&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0023607665&partnerID=8YFLogxK

M3 - Article

VL - 37

SP - 1828

EP - 1833

JO - Neurology

JF - Neurology

SN - 0028-3878

IS - 12

ER -